Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
535.27
+19.93 (3.87%)
At close: Aug 11, 2026, 4:00 PM EDT
539.00
+3.73 (0.70%)
Pre-market: Aug 12, 2026, 9:15 AM EDT
Madrigal Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $612 | Buy | Reiterates | $612 | +14.33% | Aug 12, 2026 |
| Wolfe Research | Wolfe Research | Buy Upgrades $605 | Buy | Upgrades | $605 | +13.03% | Aug 4, 2026 |
| Barclays | Barclays | Buy Maintains $964 → $962 | Buy | Maintains | $964 → $962 | +79.72% | Aug 3, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Initiates $670 | Buy | Initiates | $670 | +25.17% | Jul 31, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $709 | Buy | Reiterates | $709 | +32.46% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +15.83% | Jul 31, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $553 → $543 | Hold | Reiterates | $553 → $543 | +1.44% | Jul 31, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $644 | Buy | Maintains | $644 | +20.31% | Jul 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.